Overview
AARD market data
Price History
AARD price chart · 1M
- O
- 3.89
- H
- 3.91
- L
- 3.85
- C
- 3.91
- Vol
- 2,206.00
Daily history from Feb 13, 2025
- Source
- US equities market feed
- Observed
- Cadence
- Five-minute page cache; daily and stored hourly bars
- Status
- fresh
Key Stats & Performance
- Open
- $3.89
- Previous Close
- $3.88
- Day High
- $3.91
- Day Low
- $3.85
- 52 Week High
- $16.41
- 52 Week Low
- $3.36
- 7 Day Return
- -16.56%
- 30 Day Return
- -22.52%
- 90 Day Return
- -33.02%
- 1 Year Return
- -71.97%
- Daily Notional Volume
- $8.6K Latest daily bar volume multiplied by its closing price.
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$2.93 Diluted earnings per share over the trailing twelve months.
- Beta
- 3.81 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $3.35 – $16.60 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · market cap $84.5M · P/B 2.68.
Company News
9 captured
Aardvark Therapeutics Appoints Clinical Development Leader David Zhang, Ph.D., MBA, to its Board of DirectorsGlobenewswire Inc ·
Lowey Dannenberg, P.C. is Investigating Aardvark Therapeutics, Inc. (NASDAQ: AARD) for Potential Violations of the Federal Securities LawsGlobenewswire Inc ·